1996

110.- Charco R, Margarit C y Allende H. "Rechazo e inmunosupresión". En, Trasplante Hepático . Hepatología Gastroenterología 1996;19:419-426
111.- Charco R, Vargas V, Balseéis J, Lázaro JL, Murio JE, Jaurrieta E, Martorell J, Margarit C. Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.
J Hepatol 1996;24:452-459
112.- Balsells J, Charco R, Lázaro JL, Murio JE, Vargas V, Allende H. and Margarit C. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996;83:758-761
113.- Charco R., Vargas V, Allende H , Edo A, Balsells J., Murio JE., Lázaro JL, Bilbao I, Margarit C. Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection-. Transplant Int 1996;9[suppl 1]: S 195-7
114.- Figueras J , Busquets J, Grande L, Jaurrieta E, Pérez J , Mir J, Margarit C, López E, Vázquez J, Casanovas E , Bernados M, de Vicente E , Parrilla P, Ramón JM , Bou R. The deleterious effect of high plasma sodium of the donor and extended preservation in liver transplantation an multivariate analysis. Transplantation 1996;61:410-413
115.- Balsells J, Caragol I, Allende E, Díaz I, Charco R, Lázaro JL, Murio JE, Margarit C. DNA ploidy of hepatocellular carcinoma in cirrhotic liver. J Hepatol 1996;25:854-858
116.- B Nordlinger, M Guiguet, J Christophe Vaillant, P Balladur, Ph. Bachellier, D Jaeck, and Association Francaise de Chirurgie. Authors completed this report: Carlos Margarit et al. Surgical resection of colorectal carcinoma. Metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996;77:1254-62
web design by MediTecnologia
last update: 02/11/2005